journal article·2024-07-31

NIR-Mediated Pyroelectric Catalysis for Sustained ROS/RNS Generation and Advanced Cancer Therapy In Vivo via Injectable Hydrogel

Yandai Lin, Yanxi Yang, Xueli Ren, Zhe Liu

ACS Applied Materials & Interfaces· Volume 16· Issue 30
Publisher page

Abstract

Exogenous electrical stimulation has attracted considerable attention due to the advantages of microelectric induction and subsequent biological effects such as actin reorganization and reactive oxygen species (ROS) generation. Herein, an injectable hydrogel of BPR-ARG@Gel (BAG) with pyroelectric BPR nanoparticle loading and l -arginine (ARG) introduction was fabricated for advanced cancer therapy in vivo. Due to the photothermal effect, the holes and electrons in BPR nanoparticles were separated to produce an open-circuit voltage and consequently catalyze water H 2 O to generate toxic superoxide ( • O 2 – ) and hydroxyl radicals ( • OH). These ROS substances further oxidize ARG to produce NO for synergistic tumor treatments. The mice experiments indicated that the employment of BAG hydrogel incorporation with a near-infrared laser downregulated the heat shock protein and recruited immune cells with 5-fold-enhanced expression of proinflammatory cytokines of interferon-γ. It was also noteworthy that the injectable hydrogel of BAG substantially induced the generation of reactive oxygen/nitrogen species (ROS/RNS) with reliable biosafety and strong tumor inhibition. Overall, these findings have provided potentially new inspirations and a feasible strategy to translate this multifunctional hydrogel toward tumor therapy in a pyroelectric stimulation manner.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · MXene and MAX Phase Materials · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China

Tianjin Key Laboratory of Brain Science and Neural Engineering, Tianjin University, Tianjin 300072, China

Funding

National Natural Science Foundation of China

References (45)

Show source-provided references
1. 10.1126/science.abc622910.1126/science.abc6229 ↗
2. 10.1021/acsnano.0c0702010.1021/acsnano.0c07020 ↗
3. 10.1038/s41467-023-40954-y10.1038/s41467-023-40954-y ↗
4. 10.1002/adma.20160386410.1002/adma.201603864 ↗
5. 10.1021/acsnano.1c0061610.1021/acsnano.1c00616 ↗
6. 10.1039/D2SC01894B10.1039/D2SC01894B ↗
7. 10.1002/smll.20230948710.1002/smll.202309487 ↗
8. 10.1002/smll.20210396010.1002/smll.202103960 ↗
9. 10.1038/s41467-022-32132-310.1038/s41467-022-32132-3 ↗
10. 10.1002/adfm.20230236010.1002/adfm.202302360 ↗
11. 10.1002/adma.20210677310.1002/adma.202106773 ↗
12. 10.1002/adma.20220739110.1002/adma.202207391 ↗
13. 10.1021/acsnano.1c0904810.1021/acsnano.1c09048 ↗
14. 10.1016/j.biomaterials.2018.09.04310.1016/j.biomaterials.2018.09.043 ↗
15. 10.1021/acsnano.1c0069810.1021/acsnano.1c00698 ↗
16. 10.1021/acsnano.9b0597610.1021/acsnano.9b05976 ↗
17. 10.1002/adfm.20220655410.1002/adfm.202206554 ↗
18. 10.1016/j.cej.2024.14968810.1016/j.cej.2024.149688 ↗
19. 10.1124/pharmrev.121.00050010.1124/pharmrev.121.000500 ↗
20. 10.1021/acsbiomaterials.3c0158010.1021/acsbiomaterials.3c01580 ↗
21. 10.1002/adma.20190092710.1002/adma.201900927 ↗
22. 10.1002/adfm.20201058710.1002/adfm.202010587 ↗
23. 10.1021/acsnano.1c0608110.1021/acsnano.1c06081 ↗
24. 10.1016/j.biomaterials.2019.11968510.1016/j.biomaterials.2019.119685 ↗
25. 10.1002/anie.20201508210.1002/anie.202015082 ↗
26. 10.1002/adma.20220204410.1002/adma.202202044 ↗
27. 10.1016/j.bioactmat.2022.03.02710.1016/j.bioactmat.2022.03.027 ↗
28. 10.1016/j.apcatb.2023.12333510.1016/j.apcatb.2023.123335 ↗
29. 10.1038/nbt.333010.1038/nbt.3330 ↗
30. 10.1002/smll.20080032310.1002/smll.200800323 ↗
31. 10.1002/ange.20171048810.1002/ange.201710488 ↗
32. 10.1016/j.actbio.2017.08.02510.1016/j.actbio.2017.08.025 ↗
33. 10.1002/advs.20210344410.1002/advs.202103444 ↗
34. 10.1039/D1TB01057C10.1039/D1TB01057C ↗
35. 10.1021/acsami.2c0887010.1021/acsami.2c08870 ↗
36. 10.1016/j.actbio.2021.04.00910.1016/j.actbio.2021.04.009 ↗
37. 10.1021/acsnano.3c0589810.1021/acsnano.3c05898 ↗
38. 10.1039/D1BM00371B10.1039/D1BM00371B ↗
39. 10.1002/adma.20200197610.1002/adma.202001976 ↗
40. 10.1016/j.biomaterials.2019.11925110.1016/j.biomaterials.2019.119251 ↗
41. 10.1016/j.nantod.2021.10111010.1016/j.nantod.2021.101110 ↗
42. 10.1002/anie.20220721310.1002/anie.202207213 ↗
43. 10.1021/acsnano.9b0903210.1021/acsnano.9b09032 ↗
44. 10.1038/s41571-021-00588-910.1038/s41571-021-00588-9 ↗
45. 10.1038/s41590-020-0641-510.1038/s41590-020-0641-5 ↗